Precigen (PGEN) Construction in Progress (2012 - 2026)
Precigen's (PGEN) quarterly Construction in Progress came in at $281000.0 in Q1 2026, down 97.23% year-on-year from $10.1 million in Q1 2025, and up 1.08% on a QoQ basis from $278000.0 in Q4 2025.
Precigen (PGEN) Construction in Progress (2012 - 2026) Analysis & Trends
Precigen (PGEN) has 15 years of Construction in Progress data on file, last reported at $281000.0 in Q1 2026.
- On a quarterly basis, Construction in Progress fell 97.23% year-over-year to $281000.0 in Q1 2026; TTM through Mar 2026 was $281000.0, a 97.23% decrease from a year earlier, with the FY2025 full-year figure at $278000.0, down 96.92% from the prior year.
- Construction in Progress for Q1 2026 stood at $281000.0, up from $278000.0 in the prior quarter.
- Over the last five years, Construction in Progress for PGEN reached as high as $10.4 million in Q2 2025 and fell as low as $106000.0 in Q2 2023.
- Historically, Construction in Progress has averaged $3.7 million across 5 years, with a median of $1.2 million in 2022.
- Across the five-year window, Construction in Progress soared 7550.0% in 2024 and slumped 97.23% in 2026, its largest moves.
- Year by year, Construction in Progress stood at $531000.0 in 2022, then soared by 196.99% to $1.6 million in 2023, then surged by 471.91% to $9.0 million in 2024, then slumped by 96.92% to $278000.0 in 2025, then gained by 1.08% to $281000.0 in 2026.
- Per Business Quant data, the three most recent Construction in Progress figures were $281000.0 in Q1 2026, $278000.0 in Q4 2025, and $263000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Construction in Progress (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 137.45 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Precigen | 1.96 Bn | 1.96 Bn | 20.69 Mn | 281,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 281,000.00 |
| Dec 31, 2025 | 278,000.00 |
| Sep 30, 2025 | 263,000.00 |
| Jun 30, 2025 | 10.44 Mn |
| Mar 31, 2025 | 10.13 Mn |
| Dec 31, 2024 | 9.02 Mn |
| Sep 30, 2024 | 8.38 Mn |
| Jun 30, 2024 | 8.11 Mn |
| Mar 31, 2024 | 7.31 Mn |
| Dec 31, 2023 | 1.58 Mn |
| Sep 30, 2023 | 892,000.00 |
| Jun 30, 2023 | 106,000.00 |
| Mar 31, 2023 | 151,000.00 |
| Dec 31, 2022 | 531,000.00 |
| Sep 30, 2022 | 1.24 Mn |
| Jun 30, 2022 | 1.06 Mn |
| Mar 31, 2022 | 3.60 Mn |
| Dec 31, 2021 | 1.83 Mn |
| Sep 30, 2021 | 2.73 Mn |
| Jun 30, 2021 | 2.19 Mn |